BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 3173364)

  • 1. Comparison of the results of different therapeutic measures in 198 myasthenia gravis patients.
    Apostolski S; Lavrnić D; Djukić P; Trikić R; Gospavić J; Dotlić R; Pavlović S
    Monogr Allergy; 1988; 25():86-95. PubMed ID: 3173364
    [No Abstract]   [Full Text] [Related]  

  • 2. [Myasthenia gravis and thymectomy. Report of forty cases (author's transl)].
    Debaert A; Warin B; Hassoun A; Ribet M
    Sem Hop; 1981 Feb 8-15; 57(5-6):305-6. PubMed ID: 6259754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment and outcome of myasthenia gravis: retrospective multi-center analysis of 470 Japanese patients, 1999-2000.
    Kawaguchi N; Kuwabara S; Nemoto Y; Fukutake T; Satomura Y; Arimura K; Osame M; Hattori T;
    J Neurol Sci; 2004 Sep; 224(1-2):43-7. PubMed ID: 15450770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Myasthenia gravis. Indications, aims and methods of intensive therapy].
    Braschi A; Scherini A; Carbonera D; Mapelli A; Bellinzona G; Bobbio Pallavicini F; Dionigi R; Gasperi A
    Minerva Anestesiol; 1979 Nov; 45(11):871-81. PubMed ID: 548812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Current therapy of myasthenia].
    Zumstein V; Regli F
    Rev Med Suisse Romande; 1985 Apr; 105(4):331-8. PubMed ID: 4012144
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of therapeutic plasmapheresis in patients with generalized myasthenia during exacerbations in the late period following thymectomy].
    Marchuk AI; Golovteev VV; Sapin SM; Shagal DI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(3):330-3. PubMed ID: 3705836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transsternal thymectomy for myasthenia gravis: surgical outcome.
    Kattach H; Anastasiadis K; Cleuziou J; Buckley C; Shine B; Pillai R; Ratnatunga C
    Ann Thorac Surg; 2006 Jan; 81(1):305-8. PubMed ID: 16368387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular myasthenia gravis.
    Gilbert ME; Savino PJ
    Int Ophthalmol Clin; 2007; 47(4):93-103, ix. PubMed ID: 18049283
    [No Abstract]   [Full Text] [Related]  

  • 9. [Myasthenia gravis pseudoparalytica. Clinical picture, pathogenesis, therapy].
    Kunze K
    Med Klin; 1973 Jun; 68(22):723-30. PubMed ID: 4715780
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of ectopic thymic tissue on clinical outcome following extended thymectomy in generalized seropositive nonthymomatous myasthenia gravis.
    Ponseti JM; Gamez J; Vilallonga R; Ruiz C; Azem J; López-Cano M; Armengol M
    Eur J Cardiothorac Surg; 2008 Nov; 34(5):1062-7. PubMed ID: 18760934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Thymectomy in the management of myasthenia].
    Balzereit F; Bay V; Otto H; Rittmeyer P; Sobirey C
    Z Neurol; 1972; 201(2):136-59. PubMed ID: 4112645
    [No Abstract]   [Full Text] [Related]  

  • 12. Graded response to thymectomy in children with myasthenia gravis.
    Tracy MM; McRae W; Millichap JG
    J Child Neurol; 2009 Apr; 24(4):454-9. PubMed ID: 19339286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapeutic considerations in myasthenia gravis].
    Vejvalka J
    Cesk Neurol Neurochir; 1984 Mar; 47(2):78-84. PubMed ID: 6705094
    [No Abstract]   [Full Text] [Related]  

  • 14. [Thymus and myasthenia].
    de Crousaz G; Zoupanos G
    Rev Med Suisse Romande; 1973 Feb; 93(2):143-58. PubMed ID: 4704793
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunosuppressive therapy of myasthenia gravis].
    Lechner H; Ott E; Aranibar A
    Nervenarzt; 1976 Jun; 47(6):353-6. PubMed ID: 183158
    [No Abstract]   [Full Text] [Related]  

  • 16. Management of myasthenia gravis.
    Saperstein DS; Barohn RJ
    Semin Neurol; 2004 Mar; 24(1):41-8. PubMed ID: 15229791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Myasthenia gravis; clinical aspects, pathophysiology and treatment].
    Oosterhuis HJ
    Ned Tijdschr Geneeskd; 1983 Sep; 127(39):1765-71. PubMed ID: 6314161
    [No Abstract]   [Full Text] [Related]  

  • 18. Response to therapy in myasthenia gravis with anti-MuSK antibodies.
    Evoli A; Bianchi MR; Riso R; Minicuci GM; Batocchi AP; Servidei S; Scuderi F; Bartoccioni E
    Ann N Y Acad Sci; 2008; 1132():76-83. PubMed ID: 18567856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myasthenia gravis: clinical, immunological, and therapeutic advances.
    Romi F; Gilhus NE; Aarli JA
    Acta Neurol Scand; 2005 Feb; 111(2):134-41. PubMed ID: 15644074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of myasthenia].
    Goulon M; Estournet B; Gajdos P
    Rev Prat; 1979 Jun; 29(35):2789-99. PubMed ID: 493836
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.